Off-Target Effects with Matt Gline
Off-Target Effects with Matt Gline
Podcast Description
Matt shares a biotech CEO's perspective on the news, and he interviews other leaders about management topics important to navigating the business of drug development.
Podcast Insights
Content Themes
Covers themes including drug development management, market trends, and global biotech impacts, with episodes like the first exploring M&A trends and the influence of China's biotech industry. The podcast delves into critical topics such as investment strategies and operational challenges in the biotech space.
Matt shares a biotech CEO’s perspective on the news, and he interviews other leaders about management topics important to navigating the business of drug development.
He and Matt talk about portfolio construction, and the dynamics of taking on the right capital structure throughout different phases of a company's lifecycle. Neil shares early learnings from the commercial launch of Attruby, how being a commercial stage company can impact culture, and why he created the early-stage R&D focused sister company Gondola. Plus, discussing talent, intellectual property, and more.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.